Hydrofera LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$140Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
2,408clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Hydrofera Blue $77K associated (2023-2025)
- Hydrofera Blue Ready - Border $7,655 associated (2023-2025)
- Cutimed Sorbact $4,173 associated (2023-2025)
- Cutimed Sorbion $3,207 associated (2023-2025)
- Sorbact Other $3,126 associated (2023-2025)
- Leukomed Sorbact $1,055 associated (2023-2025)
- Hydrofera Blue Classic $236 associated (2023-2025)
- Sorbion Sorbact $104 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| James Stillerman | Watertown, NY | Surgery | $5,061.96 |
| Vitaliya Boyar | Neptune, NJ | Neonatal-Perinatal Medicine | $2,400.00 |
| Maria Aguinaga | Mission, TX | Undersea and Hyperbaric Medicine (Emergency Medicine) | $1,724.47 |
| Brock Liden | Circleville, OH | Primary Podiatric Medicine | $1,385.27 |
| Yvette Frey | Phoenix, AZ | Nurse Practitioner | $1,001.63 |
| Tammy Davis | Jackson, MS | Physician Assistant | $851.50 |
| Haklai Lau | New Britain, CT | Internal Medicine | $704.48 |
| Glenn Sloat | Albany, NY | Undersea and Hyperbaric Medicine (Emergency Medicine) | $694.01 |
| Courtney Wright | Jackson, MS | Physician Assistant | $690.42 |
| Elissa Waskiewicz | Glens Falls, NY | Family | $679.36 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.